ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: The ubiquitinated BCR-ABL binds to p62, facilitating the degradation of the BCR-ABL protein and inducing apoptosis in imatinib-resistant CML K562G cells (193).